The Medi-Globe Group has entered into a groundbreaking research cooperation with the French Institut Hospitalo-Universitaire (IHU) in Strasbourg. The goal of the collaboration is the world’s first AI software for detecting diseases of the pancreas in endoscopic ultrasound examinations. As industrial partner of the renowned IHU, the Medi-Globe Group is thus further expanding its role as an innovation leader in minimally invasive diagnostics and therapies.
Medi-Globe Group CEO Martin Lehner:
„Together with the researchers at the IHU in Strasbourg, we will develop the world’s first software for the diagnosis of diseases of the pancreas to market maturity. The key technology here is artificial intelligence.”
Marc Jablonowski, CTIO of the Medi-Globe Group:
„In the future, with the support of artificial intelligence, we will be able to make the experience of the world’s leading gastroenterologists available to all physicians. Our successful cooperation with the IHU and leading international university hospitals has the potential to revolutionize the diagnosis of pancreatic diseases and, above all, the diagnosis of pancreatic cancer“.